05-Dec-2023 - Charcot-Marie-Tooth disease type 2A: identification of a potential therapeutic approach

A recent study conducted by researchers from the “Centro Dino Ferrari”, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, and accepted for online [...]

17-Jul-2023 - The project MAINSTREAM

Primary Progressive Aphasia (PPA) is a group of neurodegenerative disorders that primarily affects language and is characterized as a progressive decline in expressing wants and [...]

29-Mar-2023 - Duchenne Muscular Distrophy: the importance of microbiota as a potential target for therapeutic interventions

Duchenne muscular dystrophy (DMD) is a progressive severe muscle-wasting disease caused by mutations in DMD gene, encoding dystrophin, that leads to loss of muscle function [...]

14-Mar-2023 - GDF5: A potential treatment for (neuro)-muscular diseases

On April 19th at 2 p.m., an English-language seminar entitled “GDF5: a potential treatment for (neuro)-muscular diseases” will be held in Room 1 of the […]